OTCMKTS:FCRE

Fc Global Realty Competitors

$0.10
-0.09 (-47.39 %)
(As of 11/11/2019)
Add
Compare
Today's Range
$0.06
Now: $0.10
$0.10
50-Day Range
$0.10
MA: $0.10
$0.10
52-Week Range
$0.03
Now: $0.10
$0.56
Volume11,300 shs
Average Volume7,405 shs
Market Capitalization$38.87 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31

Competitors

Fc Global Realty (OTCMKTS:FCRE) Vs. ABT, MDT, SYK, ISRG, BDX, and BSX

Should you be buying FCRE stock or one of its competitors? Companies in the sub-industry of "health care equipment" are considered alternatives and competitors to Fc Global Realty, including Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), and Boston Scientific (BSX).

Fc Global Realty (OTCMKTS:FCRE) and Abbott Laboratories (NYSE:ABT) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Volatility & Risk

Fc Global Realty has a beta of 2.31, meaning that its share price is 131% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

Earnings and Valuation

This table compares Fc Global Realty and Abbott Laboratories' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fc Global Realty$40,000.00971.79$-2,040,000.00N/AN/A
Abbott Laboratories$31.90 billion6.62$3.69 billion$3.2436.82

Abbott Laboratories has higher revenue and earnings than Fc Global Realty.

Profitability

This table compares Fc Global Realty and Abbott Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Fc Global Realty-4,265.28%-24.94%-9.42%
Abbott Laboratories10.50%18.19%8.29%

Institutional & Insider Ownership

72.6% of Abbott Laboratories shares are held by institutional investors. 5.0% of Fc Global Realty shares are held by insiders. Comparatively, 1.7% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for Fc Global Realty and Abbott Laboratories, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Fc Global Realty0000N/A
Abbott Laboratories121302.75

Abbott Laboratories has a consensus target price of $124.0588, suggesting a potential upside of 3.89%. Given Abbott Laboratories' higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than Fc Global Realty.

Summary

Abbott Laboratories beats Fc Global Realty on 8 of the 11 factors compared between the two stocks.

Fc Global Realty (OTCMKTS:FCRE) and Medtronic (NYSE:MDT) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.

Institutional & Insider Ownership

79.2% of Medtronic shares are held by institutional investors. 5.0% of Fc Global Realty shares are held by company insiders. Comparatively, 0.5% of Medtronic shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Fc Global Realty and Medtronic's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Fc Global Realty-4,265.28%-24.94%-9.42%
Medtronic12.69%9.71%5.30%

Valuation and Earnings

This table compares Fc Global Realty and Medtronic's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fc Global Realty$40,000.00971.79$-2,040,000.00N/AN/A
Medtronic$28.91 billion5.96$4.79 billion$4.5927.85

Medtronic has higher revenue and earnings than Fc Global Realty.

Risk and Volatility

Fc Global Realty has a beta of 2.31, suggesting that its share price is 131% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations for Fc Global Realty and Medtronic, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Fc Global Realty0000N/A
Medtronic031912.91

Medtronic has a consensus target price of $125.3333, suggesting a potential downside of 1.63%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than Fc Global Realty.

Summary

Medtronic beats Fc Global Realty on 9 of the 12 factors compared between the two stocks.

Stryker (NYSE:SYK) and Fc Global Realty (OTCMKTS:FCRE) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Insider & Institutional Ownership

71.5% of Stryker shares are held by institutional investors. 6.8% of Stryker shares are held by insiders. Comparatively, 5.0% of Fc Global Realty shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

Stryker has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Fc Global Realty has a beta of 2.31, meaning that its share price is 131% more volatile than the S&P 500.

Profitability

This table compares Stryker and Fc Global Realty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Stryker12.35%20.94%8.77%
Fc Global Realty-4,265.28%-24.94%-9.42%

Analyst Recommendations

This is a breakdown of recent recommendations for Stryker and Fc Global Realty, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Stryker061412.76
Fc Global Realty0000N/A

Stryker currently has a consensus price target of $238.4762, suggesting a potential downside of 7.57%. Given Stryker's higher possible upside, equities research analysts clearly believe Stryker is more favorable than Fc Global Realty.

Valuation & Earnings

This table compares Stryker and Fc Global Realty's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stryker$14.88 billion6.53$2.08 billion$8.2631.28
Fc Global Realty$40,000.00971.79$-2,040,000.00N/AN/A

Stryker has higher revenue and earnings than Fc Global Realty.

Summary

Stryker beats Fc Global Realty on 10 of the 12 factors compared between the two stocks.

Intuitive Surgical (NASDAQ:ISRG) and Fc Global Realty (OTCMKTS:FCRE) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Earnings & Valuation

This table compares Intuitive Surgical and Fc Global Realty's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$4.48 billion21.47$1.38 billion$9.9581.62
Fc Global Realty$40,000.00971.79$-2,040,000.00N/AN/A

Intuitive Surgical has higher revenue and earnings than Fc Global Realty.

Analyst Ratings

This is a breakdown of current ratings and price targets for Intuitive Surgical and Fc Global Realty, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Intuitive Surgical181102.50
Fc Global Realty0000N/A

Intuitive Surgical currently has a consensus target price of $750.9444, indicating a potential downside of 7.34%. Given Intuitive Surgical's higher probable upside, research analysts plainly believe Intuitive Surgical is more favorable than Fc Global Realty.

Profitability

This table compares Intuitive Surgical and Fc Global Realty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Intuitive Surgical24.45%12.08%10.44%
Fc Global Realty-4,265.28%-24.94%-9.42%

Insider & Institutional Ownership

86.5% of Intuitive Surgical shares are held by institutional investors. 1.6% of Intuitive Surgical shares are held by insiders. Comparatively, 5.0% of Fc Global Realty shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Intuitive Surgical has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Fc Global Realty has a beta of 2.31, suggesting that its stock price is 131% more volatile than the S&P 500.

Summary

Intuitive Surgical beats Fc Global Realty on 8 of the 11 factors compared between the two stocks.

Becton, Dickinson and (NYSE:BDX) and Fc Global Realty (OTCMKTS:FCRE) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends.

Risk & Volatility

Becton, Dickinson and has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Fc Global Realty has a beta of 2.31, meaning that its share price is 131% more volatile than the S&P 500.

Valuation & Earnings

This table compares Becton, Dickinson and and Fc Global Realty's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and$17.12 billion4.37$874 million$10.2025.23
Fc Global Realty$40,000.00971.79$-2,040,000.00N/AN/A

Becton, Dickinson and has higher revenue and earnings than Fc Global Realty.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Becton, Dickinson and and Fc Global Realty, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Becton, Dickinson and06702.54
Fc Global Realty0000N/A

Becton, Dickinson and currently has a consensus target price of $281.5455, indicating a potential upside of 9.22%. Given Becton, Dickinson and's higher possible upside, analysts plainly believe Becton, Dickinson and is more favorable than Fc Global Realty.

Insider and Institutional Ownership

83.2% of Becton, Dickinson and shares are owned by institutional investors. 0.8% of Becton, Dickinson and shares are owned by company insiders. Comparatively, 5.0% of Fc Global Realty shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Becton, Dickinson and and Fc Global Realty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Becton, Dickinson and5.11%13.30%5.60%
Fc Global Realty-4,265.28%-24.94%-9.42%

Summary

Becton, Dickinson and beats Fc Global Realty on 8 of the 11 factors compared between the two stocks.

Boston Scientific (NYSE:BSX) and Fc Global Realty (OTCMKTS:FCRE) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.

Profitability

This table compares Boston Scientific and Fc Global Realty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Boston Scientific36.59%11.77%5.57%
Fc Global Realty-4,265.28%-24.94%-9.42%

Institutional & Insider Ownership

90.7% of Boston Scientific shares are held by institutional investors. 0.7% of Boston Scientific shares are held by insiders. Comparatively, 5.0% of Fc Global Realty shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

Boston Scientific has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, Fc Global Realty has a beta of 2.31, indicating that its share price is 131% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Boston Scientific and Fc Global Realty, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Boston Scientific041612.86
Fc Global Realty0000N/A

Boston Scientific currently has a consensus price target of $43.6190, suggesting a potential upside of 6.49%. Given Boston Scientific's higher probable upside, equities research analysts clearly believe Boston Scientific is more favorable than Fc Global Realty.

Valuation & Earnings

This table compares Boston Scientific and Fc Global Realty's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boston Scientific$10.74 billion5.45$4.70 billion$1.5826.05
Fc Global Realty$40,000.00971.79$-2,040,000.00N/AN/A

Boston Scientific has higher revenue and earnings than Fc Global Realty.

Summary

Boston Scientific beats Fc Global Realty on 9 of the 12 factors compared between the two stocks.


Fc Global Realty Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Abbott Laboratories logo
ABT
Abbott Laboratories
2.4$119.29-4.4%$220.61 billion$31.90 billion63.12Earnings Announcement
News Coverage
Medtronic logo
MDT
Medtronic
2.7$127.81-1.3%$170.03 billion$28.91 billion48.78
Stryker logo
SYK
Stryker
2.0$258.38-0.6%$96.62 billion$14.88 billion56.05Upcoming Earnings
Analyst Revision
Intuitive Surgical logo
ISRG
Intuitive Surgical
1.7$812.14-0.1%$96.03 billion$4.48 billion92.50News Coverage
Becton, Dickinson and logo
BDX
Becton, Dickinson and
2.0$257.31-0.6%$75.24 billion$17.12 billion94.25Analyst Revision
Boston Scientific logo
BSX
Boston Scientific
2.0$41.16-0.7%$58.07 billion$10.74 billion15.77
Edwards Lifesciences logo
EW
Edwards Lifesciences
1.4$90.50-2.1%$55.09 billion$4.35 billion72.40
IDEXX Laboratories logo
IDXX
IDEXX Laboratories
1.5$530.51-0.4%$45.26 billion$2.41 billion92.42
Baxter International logo
BAX
Baxter International
1.9$87.52-1.1%$43.70 billion$11.36 billion49.73
DexCom logo
DXCM
DexCom
1.9$385.83-1.9%$38.01 billion$1.48 billion159.43
ResMed logo
RMD
ResMed
1.5$206.12-0.2%$29.93 billion$2.96 billion44.23
Teleflex logo
TFX
Teleflex
1.8$431.79-0.0%$20.19 billion$2.60 billion55.57Decrease in Short Interest
Analyst Revision
Hologic logo
HOLX
Hologic
1.9$73.47-4.4%$19.76 billion$3.78 billion17.49Analyst Revision
Insulet logo
PODD
Insulet
1.4$281.50-0.0%$18.64 billion$738.20 million639.79News Coverage
STERIS logo
STE
STERIS
2.1$209.24-0.3%$17.81 billion$3.03 billion42.44Increase in Short Interest
Varian Medical Systems logo
VAR
Varian Medical Systems
1.3$177.07-0.0%$16.26 billion$3.17 billion60.43
Abiomed logo
ABMD
Abiomed
1.4$330.63-0.4%$14.90 billion$840.88 million72.67
Masimo logo
MASI
Masimo
1.6$243.85-0.4%$13.43 billion$937.84 million63.34Upcoming Earnings
News Coverage
Hill-Rom logo
HRC
Hill-Rom
1.8$113.30-0.2%$7.53 billion$2.88 billion34.13Increase in Short Interest
Globus Medical logo
GMED
Globus Medical
1.4$69.68-0.7%$6.91 billion$785.37 million75.74Analyst Revision
Integra LifeSciences logo
IART
Integra LifeSciences
1.4$72.47-0.5%$6.15 billion$1.52 billion108.16Insider Selling
News Coverage
NuVasive logo
NUVA
NuVasive
1.1$68.53-0.3%$3.53 billion$1.17 billion-311.50Analyst Report
News Coverage
AtriCure logo
ATRC
AtriCure
1.5$68.43-1.7%$3.18 billion$230.81 million-59.50Upcoming Earnings
Integer logo
ITGR
Integer
1.6$91.76-1.4%$3.07 billion$1.26 billion41.71
Cardiovascular Systems logo
CSII
Cardiovascular Systems
1.5$38.48-0.9%$1.56 billion$236.54 million-58.30News Coverage
Alphatec logo
ATEC
Alphatec
0.8$15.64-3.8%$1.54 billion$113.43 million-14.22
AngioDynamics logo
ANGO
AngioDynamics
1.4$23.30-2.7%$912.62 million$264.16 million-5.21Decrease in Short Interest
CryoLife logo
CRY
CryoLife
2.0$22.49-0.4%$883.33 million$276.22 million-59.18
Orthofix Medical logo
OFIX
Orthofix Medical
1.2$43.90-0.3%$854.04 million$459.95 million36.58
Surmodics logo
SRDX
Surmodics
1.3$58.26-1.5%$789.04 million$94.86 million728.25
Accuray logo
ARAY
Accuray
2.3$4.96-4.0%$479.35 million$382.93 million35.43Upcoming Earnings
News Coverage
Invacare logo
IVC
Invacare
1.6$8.58-1.5%$290.88 million$927.96 million-6.98News Coverage
Rockwell Medical logo
RMTI
Rockwell Medical
1.3$0.89-2.4%$85.32 million$61.30 million-2.07
Navidea Biopharmaceuticals logo
NAVB
Navidea Biopharmaceuticals
1.7$1.52-3.3%$44.85 million$660,000.00-2.92Increase in Short Interest
ReShape Lifesciences logo
RSLS
ReShape Lifesciences
0.6$4.50-6.7%$27.75 million$15.09 million0.00Gap Down
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.